{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:37:05Z","timestamp":1772059025037,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.saa.2020.118512","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T12:25:37Z","timestamp":1589891137000},"page":"118512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["One-pot micellar augmented native fluorescence for facile fluorimetric assay of dapoxetine hydrochloride in biological plasma and tablets"],"prefix":"10.1016","volume":"239","author":[{"given":"Ahmed A.","family":"Abu-hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramadan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed M.","family":"Derayea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2020.118512_bb0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1464-410X.2006.05911.x","article-title":"Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for \u2018on-demand\u2019 treatment of premature ejaculation","volume":"97","author":"Andersson","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.saa.2020.118512_bb0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.33590\/emj\/10312297","article-title":"The role of selective serotonin reuptake inhibitors in premature ejaculation","volume":"2","author":"Aggarwal","year":"2017","journal-title":"EMJ"},{"key":"10.1016\/j.saa.2020.118512_bb0015","first-page":"120","article-title":"Spectrophotometric methods for simultaneous determination of vardenafil and dapoxetine hydrochlorides in combined dosage form","volume":"4","author":"Abdel-Moety","year":"2015","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.saa.2020.118512_bb0020","first-page":"1404","article-title":"Spectrophotometric simultaneous determination of dapoxetine and sildenafil in combined tablet dosage form by absorbance corrected method","volume":"4","author":"Chabukswar","year":"2012","journal-title":"Der. Pharma. Chem."},{"key":"10.1016\/j.saa.2020.118512_bb0025","first-page":"84","article-title":"Development and validation of spectrophotometric method for simultaneous determination of sildenafil citrate and dapoxetine hydrochloride in their combined dosage formulation","volume":"2","author":"Prajapati","year":"2014","journal-title":"PharmaTutor"},{"key":"10.1016\/j.saa.2020.118512_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2019.117611","article-title":"Quantitative determination of Dapoxetine Hydrochloride and Tadalafil using different validated spectrophotometric methods","volume":"226","author":"Magdy","year":"2020","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2020.118512_bb0035","first-page":"151","article-title":"Application of methyl orange in the spectrophotometric determination of citalopram and dapotextine in pharmaceutical formulations","volume":"6","author":"Akram","year":"2016","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.saa.2020.118512_bb0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10812-014-9963-0","article-title":"Derivative synchronous fluorescence spectroscopy for the simultaneous determination of dapoxetine hydrochloride and vardenafil in binary mixtures","volume":"81","author":"Soliman","year":"2014","journal-title":"J. Appl. Spectrosc."},{"key":"10.1016\/j.saa.2020.118512_bb0045","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/bio.3566","article-title":"Validated spectrophotometric and spectrofluorimetric methods for determination of dapoxetine hydrochloride and dosulepin hydrochloride in their dosage forms using mercurochrome","volume":"33","author":"Elama","year":"2018","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2020.118512_bb0050","first-page":"142","article-title":"Development and validation of HPTLC method for simultaneous estimation of sildenafil citrate and dapoxetine hydrochloride in combined dosage form","volume":"2","author":"Prajapati","year":"2014","journal-title":"PharmaTutor"},{"key":"10.1016\/j.saa.2020.118512_bb0055","unstructured":"D.A. Shah, K.L. Vegad, E.D. Patel, H.K. Prajapati, R.N. Patel, Y.K. Patel, Analytical method validation for estimation of avanafil and dapoxetine hydrochloride tablet dosage form by HPTLC method."},{"key":"10.1016\/j.saa.2020.118512_bb0060","first-page":"654","article-title":"Validated HPLC method for simultaneous quantitation of tadalafil and dapoxetine hydrochloride in bulk drug and formulation","volume":"4","author":"Giri","year":"2012","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.saa.2020.118512_bb0065","first-page":"393","article-title":"Stability indicating HPLC-UV method for determination of dapoxetine HCl in pharmaceutical product","volume":"71","author":"Liew","year":"2014","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.saa.2020.118512_bb0070","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1080\/10826076.2015.1087860","article-title":"RP-HPLC with time programmed fluorescence detection for quantitation of avanafil and dapoxetine hydrochloride: application to pharmaceutical dosage form and biological fluid","volume":"38","author":"Hegazy","year":"2015","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.saa.2020.118512_bb0075","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1021\/acsomega.7b01193","article-title":"Electrochemical determination of the serotonin reuptake inhibitor, dapoxetine, using cesium\u2013gold nanoparticles","volume":"2","author":"Mohamed","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.saa.2020.118512_bb0080","first-page":"277","article-title":"Electrochemical determination of dapoxetine HCl in biological fluids using coated wire electrode","volume":"10","author":"Alturiqi","year":"2016","journal-title":"J. Chem."},{"key":"10.1016\/j.saa.2020.118512_bb0085","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.170943","article-title":"Studying the association complex formation of atomoxetine and fluvoxamine with eosin Y and its application in their fluorimetric determination","volume":"5","author":"Derayea","year":"2018","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.saa.2020.118512_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.saa.2018.07.101","article-title":"Micellar spectrofluorimetric protocol for the innovative determination of HCV antiviral (daclatasvir) with enhanced sensitivity: application to human plasma and stability study","volume":"206","author":"Abdel-Lateef","year":"2019","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2020.118512_bb0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0091270006297229","article-title":"Dapoxetine has no pharmacokinetic or cognitive interactions with ethanol in healthy male volunteers","volume":"47","author":"Modi","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.saa.2020.118512_bb0100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpba.2004.10.027","article-title":"Spectrofluorimetric and micelle-enhanced spectrofluorimetric determination of gatifloxacin in human urine and serum","volume":"37","author":"Oca\u00f1a","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2020.118512_bb0105","doi-asserted-by":"crossref","first-page":"78920","DOI":"10.1039\/C5RA11635J","article-title":"Enhancement of the sensitivity of valacyclovir and acyclovir for their spectrofluorimetric determination in human plasma","volume":"5","author":"Derayea","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.saa.2020.118512_bb0110","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0731-7085(96)01759-1","article-title":"Use of micellar media for the fluorimetric determination of ellipticine in aqueous solutions","volume":"14","author":"Sbai","year":"1996","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2020.118512_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2019.104372","article-title":"Sensitive spectrofluorimetric assay based on micelle enhanced protocol for the determination of hepatitis C antiviral agent (simeprevir): application to dosage form and human plasma","volume":"152","author":"Mohammed","year":"2020","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2020.118512_bb0120","series-title":"Formulation and Evaluation of Dapoxetine HCL Nanoparticle Capsules","author":"Selvakumar","year":"2018"},{"key":"10.1016\/j.saa.2020.118512_bb0125","series-title":"International Conference on Harmonization, Geneva, Switzerland","first-page":"11","article-title":"Validation of analytical procedures: text and methodology Q2 (R1)","author":"I.H.T. Guideline","year":"2005"},{"key":"10.1016\/j.saa.2020.118512_bb0130","author":"F. FDA"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142520304911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142520304911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:32:32Z","timestamp":1761355952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142520304911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":26,"alternative-id":["S1386142520304911"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2020.118512","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-pot micellar augmented native fluorescence for facile fluorimetric assay of dapoxetine hydrochloride in biological plasma and tablets","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2020.118512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118512"}}